ArcherDX will perform whole exome sequencing of NSCLC patient samples to generate personalised ctDNA assays to test for […]

The move does not affect the firms’ ongoing collaboration

The move is based on data showing Alunbrig’s superiority over crizotinib as first-line treatment of metastatic ALK+ NSCLC

The firm has begun enrolling patients in the Phase I portion of the trial

The Solidarity trial’s expert group will review all evidence available on the drug

Researchers have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable […]

Next-gen nano technologies that can prevent infection and diagnose disease are set to transform the medical industry as […]

10 million tests have so far have been secured in a ‘landmark deal’ with industry, including Roche Diagnostics […]

Tecentriq is the first and only immune checkpoint inhibitor which has been deemed a cost effective use of […]

Samsung will provide GSK with additional flexible capacity for large-scale biopharmaceutical product manufacturing